On October 29, 2024, William Hoffman, Director at Inari Medical Inc (NARI, Financial), executed a sale of 40,000 shares of the company. The transaction was filed on the same day through an SEC Filing. Following this transaction, the insider now owns 561,233 shares of Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. The company's innovative devices are specifically designed to remove blood clots and restore healthy blood flow in the venous system.
Over the past year, the insider has sold a total of 530,000 shares and has not made any purchases. This recent sale is part of a broader trend observed at Inari Medical Inc, where there have been 34 insider sells and only 2 insider buys over the past year.
Shares of Inari Medical Inc were trading at $50.05 on the day of the transaction. The company currently holds a market cap of approximately $2.83 billion.
The stock's valuation metrics show a GF Value of $90.77, indicating a price-to-GF-Value ratio of 0.55. This suggests that Inari Medical Inc is currently seen as a Possible Value Trap, Think Twice, according to GuruFocus's valuation model.
The GF Value is calculated based on historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from analysts.
This insider sell event and the current valuation metrics provide investors with updated data points to consider when looking at their investment in Inari Medical Inc.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
